ESBATech Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $221M

  • Investors
  • 1

ESBATech General Information

Description

Developer of human antibody fragments for therapeutic applications. The company also provides drug development and development programs.

Contact Information

Website
www.esbatech.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Wagistrasse 21
  • 8952 Schlieren
  • Switzerland
+41 058
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Alcon
Corporate Office
  • Wagistrasse 21
  • 8952 Schlieren
  • Switzerland
+41 058

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ESBATech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 15-Sep-2009 $221M Completed Generating Revenue
4. Later Stage VC (Series B) 07-Aug-2008 Completed Generating Revenue
3. Early Stage VC (Series A) 21-Nov-2002 Completed Product Development
2. Seed Round Completed
1. University Spin-Out 01-Jan-1998 Completed Startup
To view ESBATech’s complete valuation and funding history, request access »

ESBATech Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
BSI-New Biomedical Frontier Venture Capital Minority
BioMedPartners Venture Capital Minority
Credit Suisse Innoventure Capital Venture Capital Minority
Angel (individual) Minority
Difasa Holding Corporation Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

ESBATech FAQs

  • When was ESBATech founded?

    ESBATech was founded in 1998.

  • Where is ESBATech headquartered?

    ESBATech is headquartered in Schlieren, Switzerland.

  • What industry is ESBATech in?

    ESBATech’s primary industry is Drug Discovery.

  • Is ESBATech a private or public company?

    ESBATech is a Private company.

  • What is the current valuation of ESBATech?

    The current valuation of ESBATech is .

  • What is ESBATech’s current revenue?

    The current revenue for ESBATech is .

  • How much funding has ESBATech raised over time?

    ESBATech has raised $80.3M.

  • Who are ESBATech’s investors?

    BSI-New Biomedical Frontier, BioMedPartners, Credit Suisse Innoventure Capital, , and Difasa Holding are 5 of 13 investors who have invested in ESBATech.

  • When was ESBATech acquired?

    ESBATech was acquired on 15-Sep-2009.

  • Who acquired ESBATech?

    ESBATech was acquired by Alcon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process